138 related articles for article (PubMed ID: 29928001)
1. Exploring the association between thyroid- stimulating hormone and metabolic syndrome: A large population-based study.
Zhou YC; Fang WH; Kao TW; Wang CC; Chang YW; Peng TC; Wu CJ; Yang HF; Chan JY; Chen WL
PLoS One; 2018; 13(6):e0199209. PubMed ID: 29928001
[TBL] [Abstract][Full Text] [Related]
2. The association of uric acid with the risk of metabolic syndrome, arterial hypertension or diabetes in young subjects- An observational study.
Chen YY; Kao TW; Yang HF; Chou CW; Wu CJ; Lai CH; Sun YS; Wang CC; Chen WL
Clin Chim Acta; 2018 Mar; 478():68-73. PubMed ID: 29278722
[TBL] [Abstract][Full Text] [Related]
3. Association of triiodothyronine levels with future development of metabolic syndrome in euthyroid middle-aged subjects: a 6-year retrospective longitudinal study.
Kim HJ; Bae JC; Park HK; Byun DW; Suh K; Yoo MH; Jae Hwan J; Kim JH; Min YK; Kim SW; Chung JH
Eur J Endocrinol; 2017 Apr; 176(4):443-452. PubMed ID: 28100631
[TBL] [Abstract][Full Text] [Related]
4. Association between blood lead levels and metabolic syndrome considering the effect of the thyroid-stimulating hormone based on the 2013 Korea National health and nutrition examination survey.
Choi JY; Huh DA; Moon KW
PLoS One; 2020; 15(12):e0244821. PubMed ID: 33382832
[TBL] [Abstract][Full Text] [Related]
5. Elevated thyroid stimulating hormone and metabolic syndrome risk in patients with first-episode and drug-naïve major depressive disorder: a large-scale cross-sectional study.
Zhang Q; Dong G; Zhu X; Cao Y; Zhang X
BMC Psychiatry; 2024 May; 24(1):380. PubMed ID: 38773550
[TBL] [Abstract][Full Text] [Related]
6. Association between serum magnesium concentration and metabolic syndrome, diabetes, hypertension and hyperuricaemia in knee osteoarthritis: a cross-sectional study in Hunan Province, China.
Wang Y; Wei J; Zeng C; Yang T; Li H; Cui Y; Xie D; Xu B; Liu Z; Li J; Jiang S; Lei G
BMJ Open; 2018 Sep; 8(9):e019159. PubMed ID: 30206073
[TBL] [Abstract][Full Text] [Related]
7. Variations in Serum Free Thyroxine Concentration Within the Reference Range Predicts the Incidence of Metabolic Syndrome in Non-Obese Adults: A Cohort Study.
Mehran L; Amouzegar A; Bakhtiyari M; Mansournia MA; Rahimabad PK; Tohidi M; Azizi F
Thyroid; 2017 Jul; 27(7):886-893. PubMed ID: 28486021
[TBL] [Abstract][Full Text] [Related]
8. Normal thyroid-stimulating hormone levels, autoimmune activation, and coronary heart disease risk.
Onat A; Aydın M; Can G; Çelik E; Altay S; Karagöz A; Ademoğlu E
Endocrine; 2015 Feb; 48(1):218-26. PubMed ID: 24794068
[TBL] [Abstract][Full Text] [Related]
9. Thyroid function and metabolic syndrome in the population-based LifeLines cohort study.
Wolffenbuttel BHR; Wouters HJCM; Slagter SN; van Waateringe RP; Muller Kobold AC; van Vliet-Ostaptchouk JV; Links TP; van der Klauw MM
BMC Endocr Disord; 2017 Oct; 17(1):65. PubMed ID: 29037214
[TBL] [Abstract][Full Text] [Related]
10. Fat-to-muscle ratio is a useful index for cardiometabolic risks: A population-based observational study.
Chen YY; Fang WH; Wang CC; Kao TW; Yang HF; Wu CJ; Sun YS; Wang YC; Chen WL
PLoS One; 2019; 14(4):e0214994. PubMed ID: 30964893
[TBL] [Abstract][Full Text] [Related]
11. THYROID FUNCTION AND METABOLIC SYNDROME: A CROSS-SECTIONAL STUDY IN OBESE AND OVERWEIGHT PATIENTS.
Kommareddy S; Lee SY; Braverman LE; Pearce EN
Endocr Pract; 2015 Nov; 21(11):1204-10. PubMed ID: 26214105
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of the metabolic syndrome increases through the quartiles of thyroid stimulating hormone in a population-based sample of euthyroid subjects.
Shinkov A; Borissova AM; Kovatcheva R; Atanassova I; Vlahov J; Dakovska L
Arq Bras Endocrinol Metabol; 2014 Dec; 58(9):926-32. PubMed ID: 25627048
[TBL] [Abstract][Full Text] [Related]
13. Thyroid hormones, metabolic syndrome and Vitamin D in middle-aged and older euthyroid subjects: a preliminary study.
Verrusio W; Magro VM; Renzi A; Casciaro B; Andreozzi P; Cacciafesta M
Aging Clin Exp Res; 2019 Sep; 31(9):1337-1341. PubMed ID: 30406357
[TBL] [Abstract][Full Text] [Related]
14. Association of Percentage Body Fat and Metabolic Health in Offspring of Patients with Cardiovascular Diseases.
Chen YY; Fang WH; Wang CC; Kao TW; Chang YW; Yang HF; Wu CJ; Sun YS; Chen WL
Sci Rep; 2018 Sep; 8(1):13831. PubMed ID: 30218093
[TBL] [Abstract][Full Text] [Related]
15. Association between thyroid-stimulating hormone and blood pressure in adults: an 11-year longitudinal study.
Langén VL; Niiranen TJ; Puukka P; Sundvall J; Jula AM
Clin Endocrinol (Oxf); 2016 May; 84(5):741-7. PubMed ID: 26261034
[TBL] [Abstract][Full Text] [Related]
16. Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women.
Park HT; Cho GJ; Ahn KH; Shin JH; Hong SC; Kim T; Hur JY; Kim YT; Lee KW; Kim SH
Maturitas; 2009 Mar; 62(3):301-5. PubMed ID: 19250778
[TBL] [Abstract][Full Text] [Related]
17. Association between thyroid dysfunction and dysglycaemia: a prospective cohort study.
Chang CH; Yeh YC; Shih SR; Lin JW; Chuang LM; Caffrey JL; Tu YK
Diabet Med; 2017 Nov; 34(11):1584-1590. PubMed ID: 28710779
[TBL] [Abstract][Full Text] [Related]
18. Low-density lipoprotein cholesterol and metabolic syndrome in an Iranian high-risk population.
Janghorbani M; Amini M
Diabetes Metab Syndr; 2015; 9(2):91-7. PubMed ID: 25108602
[TBL] [Abstract][Full Text] [Related]
19. Elevated thyroid stimulating hormone levels are associated with metabolic syndrome in euthyroid young women.
Oh JY; Sung YA; Lee HJ
Korean J Intern Med; 2013 Mar; 28(2):180-6. PubMed ID: 23525791
[TBL] [Abstract][Full Text] [Related]
20. The impact of metabolic syndrome on chronic kidney disease development. Insights from a big prospective study.
Fanaei SM; Mehran L; Amouzegar A; Masoumi S; Amouzegar A; Azizi F
Eur J Clin Invest; 2023 Apr; 53(4):e13945. PubMed ID: 36576367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
